Hain Celestial Group, Inc. — Form 10-Q Summary
Period: Fiscal third quarter and nine months ended March 31, 2015. The request metadata says “2014 Q3,” but the filing itself reports the quarter ended March 31, 2015. Amounts below are in millions unless noted.
Business context and reporting period
Hain manufactures and sells organic and natural food, beverage, and personal care products. It operates in the United States, United Kingdom, Hain Pure Protein, Canada, and Europe. Results include several acquisitions; HPPC and Empire became wholly owned during the period, and Belvedere was acquired in February 2015.
Financial performance and changes versus prior year
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Net sales | $662.7 vs. $557.4; +18.9% | $1,990.4 vs. $1,569.8; +26.8% |
| Gross profit / margin | $157.7 / 23.8% vs. $152.8 / 27.4% | $450.9 / 22.7% vs. $415.0 / 26.4% |
| Operating income / margin | $60.2 / 9.1% vs. $63.6 / 11.4% | $163.0 / 8.2% vs. $167.7 / 10.7% |
| Net income | $33.4 vs. $35.2 | $96.8 vs. $104.1 |
| Diluted EPS | $0.32 vs. $0.34 | $0.94 vs. $1.05 |
| Operating cash flow | Not provided separately for the quarter | $70.2 vs. $122.3 |
| Operating free cash flow | Not provided separately for the quarter | $33.9 vs. $91.6 |
Quarterly sales growth was primarily acquisition-related: HPPC, Empire, and Rudi’s contributed approximately $100 million. Nine-month growth also reflected Tilda’s inclusion for more of the current period. Foreign exchange reduced quarterly sales by $26.3 million and nine-month sales by approximately $26 million. Excluding acquisitions and other mix effects, the filing does not provide a single organic-growth figure.
Margins and earnings declined despite higher sales. The nine-month nut butter recall charges totaled $32.3 million, including $15.8 million of customer returns, $11.6 million of inventory and cost-of-sales charges, and $4.9 million of refunds and administration. Other pressures included higher input costs, product mix and trade spending, UK factory start-up costs, integration expenses, and the lower margins of Hain Pure Protein. Quarterly operating income also included a $5.5 million non-cash impairment of the New Covent Garden Soup Co. trade name.
Cash, debt, and liquidity
- Cash was $100.3 million at March 31, 2015, down from $123.8 million at June 30, 2014. Working capital was $538.2 million, up from $379.4 million.
- Total debt was $879.0 million, including $692.4 million outstanding on the revolving credit facility and $150 million of 5.98% senior notes due May 2016. The credit facility borrowings were up from $614.5 million at June 30, 2014.
- The company had a $1 billion unsecured revolving facility, expiring December 2019, with an additional uncommitted $350 million potentially available subject to conditions. It reported compliance with no covenant breach stated in the filing.
- Nine-month operating cash flow of $70.2 million was reduced by working-capital needs and recall costs. Investing cash use was $137.5 million, including $104.4 million net for acquisitions and $36.3 million in capital expenditures. Financing provided $55.0 million.
- Management expected fiscal 2015 capital spending of approximately $45 million and stated that cash, projected operating cash flows, and credit availability should cover ordinary working-capital and other expected needs for at least 12 months. The company intends to refinance the $150 million notes due in 2016.
Outlook, management commentary, risks, and unusual items
- The filing discusses the company’s fiscal 2015 guidance as a risk to achieving, but the provided text does not state a clear numerical net-sales or diluted-EPS guidance value.
- Management cited foreign-exchange headwinds, volatile and higher input costs, global economic and political uncertainty, and consumer demand as ongoing challenges. It described productivity, cost savings, sourcing initiatives, and selective price increases as mitigation measures.
- A fire at Tilda’s rice-milling facility led to temporary reliance on co-packers and affected product availability and timing. The company said it was insured for related costs; remaining milling lines were expected to be functional by the end of calendar 2015.
- The company said it was finalizing the nut butter recall matter with the FDA and did not anticipate further material charges. This remains an important estimate and contingency to monitor.
- Foreign currency translation reduced accumulated other comprehensive income by $167.1 million over the nine months. Management estimated that a 5% weakening in relevant foreign currencies versus the U.S. dollar would have reduced nine-month sales by about $38 million and operating income by about $2.5 million.
- Other risks include poultry disease or food-borne illness affecting Hain Pure Protein, acquisition integration, input-cost inflation, product recalls, litigation, and potential impairment of goodwill or intangible assets. A putative class action over historical Avalon Organics and JASON product labels remained in discovery; the company said it would defend the case.
Most important facts for investors to verify
- Confirm the fiscal-year period and the distinction between acquisition-driven sales growth and underlying organic growth.
- Track gross and operating margin recovery after recall costs, lower-margin poultry sales, factory start-up costs, and trade spending.
- Review the final FDA resolution and any costs beyond the $32.3 million recorded for the recall in the nine-month period.
- Monitor operating cash conversion, inventory and receivables, acquisition-related funding, and debt levels; assess refinancing plans for the 2016 senior notes.
- Check progress on Tilda’s mill restoration and whether insurance proceeds cover disruption-related costs.
- Assess foreign-exchange exposure, poultry disease and food-safety risks, and future impairment or contingent-consideration adjustments.